Class information for:
Level 1: BRAIN TUMOR PROGRAM//GLIOMA IMMUNOTHER Y GRP//GL261

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
7665 1262 49.4 80%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
151 22214 IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 BRAIN TUMOR PROGRAM Address 9 30% 2% 25
2 GLIOMA IMMUNOTHER Y GRP Address 7 50% 1% 10
3 GL261 Author keyword 4 47% 1% 7
4 GLIOMA VACCINE Author keyword 4 75% 0% 3
5 MOL MED HLTH CARE GRP Address 3 100% 0% 3
6 CHILD WOMAN Address 3 60% 0% 3
7 DENDRITIC CELL BASED IMMUNOTHERAPY Author keyword 3 60% 0% 3
8 MED ONCOL IMMUNOTHER Y PROGRAM Address 3 60% 0% 3
9 MAXINE DUNITZ NEUROSURG Address 3 11% 2% 22
10 INTERLEUKIN 13 RECEPTOR ALPHA 2 Author keyword 2 44% 0% 4

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 GL261 4 47% 1% 7 Search GL261 Search GL261
2 GLIOMA VACCINE 4 75% 0% 3 Search GLIOMA+VACCINE Search GLIOMA+VACCINE
3 DENDRITIC CELL BASED IMMUNOTHERAPY 3 60% 0% 3 Search DENDRITIC+CELL+BASED+IMMUNOTHERAPY Search DENDRITIC+CELL+BASED+IMMUNOTHERAPY
4 INTERLEUKIN 13 RECEPTOR ALPHA 2 2 44% 0% 4 Search INTERLEUKIN+13+RECEPTOR+ALPHA+2 Search INTERLEUKIN+13+RECEPTOR+ALPHA+2
5 AUTOLOGOUS FORMALIN FIXED TUMOR VACCINE 2 67% 0% 2 Search AUTOLOGOUS+FORMALIN+FIXED+TUMOR+VACCINE Search AUTOLOGOUS+FORMALIN+FIXED+TUMOR+VACCINE
6 GLIOMA ASSOCIATED ANTIGEN 2 67% 0% 2 Search GLIOMA+ASSOCIATED+ANTIGEN Search GLIOMA+ASSOCIATED+ANTIGEN
7 VACCINATION THERAPY 1 38% 0% 3 Search VACCINATION+THERAPY Search VACCINATION+THERAPY
8 CDX 110 1 50% 0% 2 Search CDX+110 Search CDX+110
9 MOUSE GLIOMA 1 100% 0% 2 Search MOUSE+GLIOMA Search MOUSE+GLIOMA
10 MOUSE INTERFERON ALPHA BETA MUIFN ALPHA BETA 1 100% 0% 2 Search MOUSE+INTERFERON+ALPHA+BETA+MUIFN+ALPHA+BETA Search MOUSE+INTERFERON+ALPHA+BETA+MUIFN+ALPHA+BETA

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PRIMARY INTRACRANIAL TUMORS 72 59% 6% 82
2 AUTOLOGOUS GLIOMA 23 100% 1% 10
3 GRADE III IV ASTROCYTOMA 18 89% 1% 8
4 EXPERIMENTAL RAT GLIOMA 15 71% 1% 12
5 GENE TRANSFECTED FIBROBLASTS 15 88% 1% 7
6 RECURRENT GLIOMA 14 37% 2% 30
7 CYTOKINE GENE THERAPY 11 39% 2% 23
8 GLIOMA ASSOCIATED ANTIGEN 9 83% 0% 5
9 MURINE GLIOMA 8 70% 1% 7
10 INTRACRANIAL GLIOMAS 8 37% 1% 18

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
MODULATION OF T-CELL FUNCTION BY GLIOMAS 1991 206 33 73%
Microglia and Macrophages in Malignant Gliomas: Recent Discoveries and Implications for Promising Therapies 2013 17 49 49%
Immunotherapy for the Treatment of Glioblastoma 2012 11 84 65%
CNS macrophages and peripheral myeloid cells in brain tumours 2014 9 163 28%
Active immunotherapy using dendritic cells in the treatment of glioblastoma multiforme 2013 14 43 42%
The molecular profile of microglia under the influence of glioma 2012 37 266 24%
Immunotherapy advances for glioblastoma 2014 7 238 30%
Understanding the role of cytokines in Glioblastoma Multiforme pathogenesis 2012 21 97 34%
Microglia function in brain tumors 2005 128 90 33%
Immune defects observed in patients with primary malignant brain tumors 1999 161 172 31%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 BRAIN TUMOR PROGRAM 9 30% 2.0% 25
2 GLIOMA IMMUNOTHER Y GRP 7 50% 0.8% 10
3 MOL MED HLTH CARE GRP 3 100% 0.2% 3
4 CHILD WOMAN 3 60% 0.2% 3
5 MED ONCOL IMMUNOTHER Y PROGRAM 3 60% 0.2% 3
6 MAXINE DUNITZ NEUROSURG 3 11% 1.7% 22
7 CLIN SCI K3 805 2 67% 0.2% 2
8 NEUROSURG CLIN SCI 2 67% 0.2% 2
9 GABRIELE BARTOLI BRAIN TUMOR 2 33% 0.4% 5
10 UNIT MOL NEUROONCOL 2 31% 0.4% 5

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000147030 SERBSKY SOCIAL FORENS PSYCHIAT//BRAIN ADJACENT TO TUMOR//BRAIN TUMOR TISSUE BANK
2 0.0000117753 CELL BIOL IMMUNOL SECT//HUMAN NEURAL DEVELOPMENT//LEWIS THOMAS S 123
3 0.0000095684 ADV CELL MOL THER Y//SHUNDE PEOPLES HOSP//TUMOR VACCINE
4 0.0000082715 EGFRVIII//RECURRENT GLIOBLASTOMA//TUMOR TREATING FIELDS
5 0.0000077968 BRAIN TUMOR STEM CELL//GLIOMA STEM CELLS//BRAIN TUMOR STEM CELLS
6 0.0000077624 TUMOR INFILTRATING LYMPHOCYTES//ADOPTIVE IMMUNOTHERAPY//AUTOLYMPHOCYTE THERAPY
7 0.0000073726 ADENOVIRAL MEDIATED INTERFERON ALPHA//GENE IMMUNE MED//CANC BIOL 173
8 0.0000073379 INHIBITORY MODULATION//TAC ANTIGEN//PROGRAMA NEUROIMUNOL NEUROBIOL
9 0.0000063855 ARACHNOID GRANULATIONS//ARACHNOID VILLI//CEREBROSPINAL FLUID ABSORPTION
10 0.0000063514 TEMOZOLOMIDE//GLIOBLASTOMA MULTIFORME//ANAPLASTIC ASTROCYTOMA